DSGN

DSGN · Design Therapeutics Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

Design Therapeutics to Present at Cantor Fitzgerald Healthcare Conference. Design Therapeutics will participate in the 2026 Cantor Fitzgerald Global Healthcare Conference. These events give companies a platform to engage with institutional investors and present their programs. The stock has traded within a 52-week range of $5.28 to $17.25, with analysts maintaining an average price target of $21.00.

this person other insiders at DSGN

Insiders & Stakes

George Simeon
Director
6,526,476
Shares held
SR One Capital Fund I Aggregator LP
10% Owner
6,526,476
Shares held
Xu Stella
Director
4,129,950
Shares held
William Arsani
Director
1,000,000
Shares held
LAPPE RODNEY W
Director
133,024
Shares held
Siffert Joao MD
President and CEO
132,619
Shares held
John P. Schmid
Director
26,965
Shares held
Prasad Deepa
Director
20,000
Shares held
Berger Heather A.1,300
Shares held

Transaction History

William Arsani▼ Sell$1.8M
William Arsani▼ Sell$1.1M
Prasad Deepa▼ Sell$24K
William Arsani▼ Sell$3.5M
John P. Schmid▲ Buy$67K
Berger Heather A.▲ Buy$5K
John P. Schmid▲ Buy$33K
LAPPE RODNEY W▲ Buy$49K
Prasad Deepa▲ Buy$28K
William Arsani▲ Buy$4.8M
William Arsani▲ Buy$591K
SR One Capital Fund I Aggregator LP▲ Buy$325K
Siffert Joao MD▲ Buy$53K
George Simeon▲ Buy$325K
SR One Capital Fund I Aggregator LP▲ Buy$3.1M
Siffert Joao MD▲ Buy$10K
George Simeon▲ Buy$3.1M
George Simeon▲ Buy$4.1M
SR One Capital Fund I Aggregator LP▲ Buy$4.1M
LAPPE RODNEY W▲ Buy$119K
Xu Stella▼ Sell$27K
William Arsani▲ Buy$475K
Xu Stella▼ Sell$456K
Xu Stella▼ Sell$10.5M
Xu Stella▼ Sell$268K
Prasad Deepa▼ Sell$0
William Arsani▲ Buy$618K

We use analytics to understand how market-wall is used. No personal data is sold.